立足资源优势保护环境和濒危药源发展中国银杏药业——恒源药业(集团)公司发展模式探讨  

Developing Medicines of Ginkgo Biloba in China on the Basis of Resource Superiority and Protection of Environment and Endangered Medicinal Resources -Exploration on Development Pattern of hengyuan Pharmaceutical (Group) Corporation

作　　者：罗莉兰[1] 盛克敏[1] 

机构地区：[1]西南交通大学,成都610031

出　　处：《世界科学技术-中药现代化》2002年第2期46-48,共3页World Science and Technology(Modernization of Traditional Chinese Medicine)

摘　　要：本文分析了我国银杏资源及相关产品、产业现状,并对恒源药业(集团)的发展模式进行了研究、分析。This article analyzes the present situation in the development of the medicines made of ginkgo biloba in China and discusses the pattern created by Hengyuan Pharmaceutical Corporation for the development of the said medicines.

关 键 词：银杏药业 中药企业 中国 环境保护 濒危药源 恒源药业 

分 类 号：F426.7[经济管理—产业经济]